Back to Journals » Clinical Ophthalmology » Volume 13

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Total article views   HTML views PDF downloads Totals
5,584 Dovepress* 5,377+ 1,468 6,845
PubMed Central* 207 78 285
Totals 5,584 1,546 7,130
*Since 24 January 2019

View citations on PubMed Central and Google Scholar